One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Wound Care Biologics Market

[ 英語タイトル ] Wound Care Biologics Market by Product (Biological Skin Substitutes (Biosynthetic Products), Topical Agents), Wound Type (Diabetic Foot Ulcer, Pressure Ulcers, Surgical & Traumatic Wound), End User (Hospitals, Burn Centers) - Global Forecast to 2023


Product Code : MNMHC00109860
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The wound care biologics market is projected to grow at a CAGR of 9.8% during the forecast period.”
The wound care biologics market is expected to reach USD 2.26 billion by 2023 from USD 1.42 billion in 2018, at a CAGR of 9.8%. Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. On the other hand, the high cost of wound care biologics and the higher rejection rate associated with skin grafts & substitutes will restrain the growth of this market.
“The biological skin substitute segment is anticipated to grow at the fastest rate in the next five years.”
Based on product, the wound care biologics market is segmented into biologic skin substitutes and topical agents. The biological skin substitutes segment is estimated to account for the largest share in 2018 and grow at the highest rate from 2018 to 2023. The rising incidence of hard-to-heal wounds and their growing adoption (due to their high efficacy) are driving the growth of this product segment. The biological skin substitutes segment is further categorized into human donor tissue-derived products, acellular animal-derived products, and biosynthetic products.
“Asia Pacific is estimated to grow at the highest CAGR during the study period.”
Geographically, the wound care biologics market was dominated by North America, followed by Europe in 2017. The Asia Pacific market is estimated to register the highest growth during the forecast period primarily due to the presence of a large patient population, increasing penetration of key market players, and the large number of research and development activities for wound care biologic products.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1–35%, Tier 2–22% and Tier 3- 43%
• By Designation: C-level–15%, Director-level–32%, Others–53%
• By Region: North America–34%, Europe–27%, Asia Pacific–23%, Rest of the World–16%

The major players in this market are Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), and Marine Polymer Technologies, Inc. (US).
Research Coverage:
The report analyses the wound care biologics market by product, wound type, method, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.
Key Benefits of Buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the wound care biologics market
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the wound care biologics market
• Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the wound care biologics market
• Market Development: Comprehensive information about emerging markets. This report analyses the market for various wound care biologics across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the wound care biologics market.

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.2.1 MARKETS COVERED 13
1.2.2 YEARS CONSIDERED FOR THE STUDY 13
1.3 CURRENCY 14
1.4 LIMITATIONS 14
1.5 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 SECONDARY DATA 16
2.1.1 KEY DATA FROM SECONDARY SOURCES 16
2.2 PRIMARY DATA 17
2.2.1 KEY DATA FROM PRIMARY SOURCES 18
2.3 MARKET SIZE ESTIMATION 18
2.3.1 BOTTOM-UP APPROACH 19
2.3.2 TOP-DOWN APPROACH 20
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.5 ASSUMPTIONS FOR THE STUDY 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 26
4.1 WOUND CARE BIOLOGICS MARKET OVERVIEW 26
4.2 GEOGRAPHIC ANALYSIS: WOUND CARE BIOLOGICS MARKET, BY PRODUCT (2018) 27
4.3 GEOGRAPHIC SNAPSHOT OF THE WOUND CARE BIOLOGICS MARKET 28
4.4 WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 REIMBURSEMENT SCENARIO FOR SKIN SUBSTITUTES IN THE US 30
5.2.1 GENERAL CRITERIA COVERED 30
5.2.2 APLIGRAF, THERASKIN, AND EPIFIX 30
5.2.3 DERMAGRAFT 31
5.2.4 INTEGRA 31
5.3 MARKET DYNAMICS 32
5.3.1 DRIVERS 32
5.3.1.1 Rising incidences of burn injuries 32
5.3.1.2 Rapid growth in the geriatric population 33
5.3.1.3 Growing incidence of ulcers and target conditions 34
5.3.1.4 Innovation in wound care biologics 36
5.3.1.5 Awareness programs for wound care treatment and management 36
5.3.2 MARKET RESTRAINTS 37
5.3.2.1 High cost of wound treatment and wound care biologics 37
5.3.2.2 Risk of skin substitute failure 37
5.3.3 MARKET OPPORTUNITIES 38
5.3.3.1 Increasing research on advanced wound treatments 38
5.3.3.2 3D skin printing 38
6 WOUND CARE BIOLOGICS MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 BIOLOGICAL SKIN SUBSTITUTES 41
6.2.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS 42
6.2.2 ACELLULAR ANIMAL-DERIVED PRODUCTS 43
6.2.3 BIOSYNTHETIC PRODUCTS 44
6.3 TOPICAL AGENTS 45
7 WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 46
7.1 INTRODUCTION 47
7.2 ULCERS 48
7.2.1 DIABETIC FOOT ULCERS 50
7.2.2 VENOUS ULCERS 51
7.2.3 PRESSURE ULCERS 52
7.2.4 OTHER ULCERS 53
7.3 SURGICAL & TRAUMATIC WOUNDS 54
7.4 BURNS 56
8 WOUND CARE BIOLOGICS MARKET, BY END USER 58
8.1 INTRODUCTION 59
8.2 HOSPITALS 60
8.3 AMBULATORY SURGICAL CENTERS 61
8.4 BURN CENTERS AND WOUND CLINICS 62
9 WOUND CARE BIOLOGICS MARKET, BY REGION 63
9.1 INTRODUCTION 64
9.2 NORTH AMERICA 65
9.2.1 US 68
9.2.2 CANADA 70
9.3 EUROPE 72
9.3.1 UK 74
9.3.2 GERMANY 75
9.3.3 FRANCE 77
9.3.4 ROE 78
9.4 ASIA PACIFIC 80
9.4.1 CHINA 83
9.4.2 JAPAN 85
9.4.3 REST OF ASIA PACIFIC 86
9.5 REST OF THE WORLD 88
10 COMPETITIVE LANDSCAPE 90
10.1 OVERVIEW 90
10.2 MARKET SHARE RANKING, 2017 91
10.3 TOP RANKING COMPANIES IN THE WOUND CARE BIOLOGICS MARKET 91
10.4 WOUND CARE BIOLOGICS MARKET SHARE ANALYSIS IN THE US, 2017 91
10.5 COMPETITIVE SCENARIO 92
10.5.1 PRODUCT LAUNCHES AND APPROVALS 92
10.5.2 AGREEMENTS 93
10.5.3 ACQUISITIONS 93
10.5.4 EXPANSIONS 93
10.5.5 OTHER DEVELOPMENTS 94
11 COMPANY PROFILES 95
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 SMITH & NEPHEW 95
11.2 MÖLNLYCKE HEALTH CARE AB (INVESTOR AB) 97
11.3 INTEGRA LIFESCIENCES 99
11.4 WRIGHT MEDICAL 101
11.5 MIMEDX GROUP 103
11.6 VERICEL 105
11.7 ANIKA THERAPEUTICS 107
11.8 OSIRIS THERAPEUTICS 109
11.9 ORGANOGENESIS 111
11.10 KERECIS 112
11.11 SOLSYS MEDICAL 113
11.12 ACELL 114
11.13 MARINE POLYMER TECHNOLOGIES 115

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12 APPENDIX 116
12.1 INSIGHTS FROM INDUSTRY EXPERTS 116
12.2 DISCUSSION GUIDE 117
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 119
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 121
12.5 AVAILABLE CUSTOMIZATIONS 122
12.6 RELATED REPORTS 122
12.7 AUTHOR DETAILS 123

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+